Vimarsana
Biggest News Aggregation in the World

Page 6 - Director Beth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director Beth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Beth Today - Breaking & Trending Today

Acelyrin (NASDAQ:SLRN) Sets New 1-Year Low at $20.00 - Vimarsana News

Acelyrin (NASDAQ:SLRN) Sets New 1-Year Low at $20.00

Shares of Acelyrin, Inc. (NASDAQ:SLRN – Get Rating) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $20.00 and last traded at $20.03, with a volume of 12375 shares trading hands. The stock had previously closed at $20.72. Acelyrin Price Performance Insider Transactions at Acelyrin In related […]

Source: wkrb13.com
Vera Therapeutics (NASDAQ:VERA) PT Raised to $9.00 at Wedbush - Vimarsana News

Vera Therapeutics (NASDAQ:VERA) PT Raised to $9.00 at Wedbush

Vera Therapeutics (NASDAQ:VERA – Get Rating) had its price objective increased by Wedbush from $6.00 to $9.00 in a research note released on Friday, The Fly reports. Wedbush also issued estimates for Vera Therapeutics’ Q1 2024 earnings at ($0.62) EPS, Q2 2024 earnings at ($0.64) EPS, Q3 2024 earnings at ($0.66) EPS and Q4 2024 […]

HC Wainwright Cuts Vera Therapeutics (NASDAQ:VERA) Price Target to $10.00 - Vimarsana News

HC Wainwright Cuts Vera Therapeutics (NASDAQ:VERA) Price Target to $10.00

Vera Therapeutics (NASDAQ:VERA – Get Rating) had its price objective reduced by HC Wainwright from $11.00 to $10.00 in a research note issued to investors on Friday morning, The Fly reports. Separately, JPMorgan Chase & Co. lowered their price objective on Vera Therapeutics from $38.00 to $22.00 and set an overweight rating on the stock […]

Source: wkrb13.com
Acelyrin, Inc. (NASDAQ:SLRN) Director Beth C. Seidenberg Buys 60,000 Shares - Vimarsana News

Acelyrin, Inc. (NASDAQ:SLRN) Director Beth C. Seidenberg Buys 60,000 Shares

Acelyrin, Inc. (NASDAQ:SLRN – Get Rating) Director Beth C. Seidenberg acquired 60,000 shares of the firm’s stock in a transaction on Tuesday, May 9th. The shares were purchased at an average cost of $18.00 per share, for a total transaction of $1,080,000.00. Following the completion of the purchase, the director now directly owns 60,000 shares […]

Source: wkrb13.com
Acelyrin, Inc. (NASDAQ:SLRN) Director Beth C. Seidenberg Acquires 60,000 Shares - Vimarsana News

Acelyrin, Inc. (NASDAQ:SLRN) Director Beth C. Seidenberg Acquires 60,000 Shares

Acelyrin, Inc. (NASDAQ:SLRN – Get Rating) Director Beth C. Seidenberg acquired 60,000 shares of the stock in a transaction dated Tuesday, May 9th. The shares were bought at an average cost of $18.00 per share, with a total value of $1,080,000.00. Following the transaction, the director now directly owns 60,000 shares of the company’s stock, […]